Biological Therapies for Asthma: Targeting Type 1 and Type 2 Inflammation
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 1806
Special Issue Editors
Interests: asthma; airway inflammation; physiology; cardiometabolic disease; molecular biology
Special Issue Information
Dear Colleagues,
Asthma is a complex and varied disease driven by different types of inflammation, mainly type 1 and type 2. While type 1 inflammation, often associated with non-allergic asthma, remains less understood and harder to treat, recent advances are starting to shed light on its mechanisms and potential treatment targets. On the other hand, type 2 inflammation is linked to allergic asthma and driven by cytokines like IL-4, IL-5, and IL-13. Type 2 inflammation has been the focus of many effective biological therapies now available in clinical practice.
This Special Issue invites contributions that explore the role of biological therapies in targeting both the type 1 and type 2 inflammation in asthma. We aim to cover the following topics:
- The biological mechanisms driving type 1 and type 2 inflammation and how they shape asthma subtypes.
- New and existing biological treatments for both types of inflammation, including their clinical benefits and limitations.
- Biomarkers that help identify type 1 and type 2 inflammation and predict responses to treatment.
- Comparative studies on outcomes, effectiveness, and challenges in treating these two types of inflammation.
- Personalized treatment approaches based on inflammatory patterns of asthma.
By bringing together insights from researchers and clinicians, this Special Issue aims to advance our understanding of how biologicals can be used to address the different inflammatory processes in asthma, paving the way for more personalized and effective treatments.
Dr. Mohammad Irshad Reza
Dr. Nilesh Sudhakar Ambhore
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- asthma endotypes
- type 1 inflammation
- type 2 inflammation
- biological therapies for asthma
- non-type 2 asthma
- cytokine pathways in asthma
- precision medicine in asthma
- inflammatory biomarkers in asthma
- Th1/Th2 immune responses
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.